Medical/Pharmaceuticals

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-The-Art Testing Laboratory

PHILADELPHIA, Nov. 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies Inc. (WuXi ATU) – a business unit of WuXi AppTec offering end-to-end contract services for the cell and gene therapies industry – today announced the completion of a facility expansion that will triple its advanced testing capaci...

2020-11-18 21:00 1737

Samsung Biologics breaks ground on Super Plant, the world's largest and most innovative bio-manufacturing facility

INCHEON, South Korea, Nov. 18, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) officially began construction of its Plant 4 in Incheon,South Korea. Dubbed the "Super Plant," the new, multi-story 238,000-square-meter construction will be the world's largest biopharmaceutical manufacturing ...

2020-11-18 20:00 1820

Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments

INDIANAPOLIS and INCHEON, South Korea, Nov. 17, 2020 /PRNewswire/ -- Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lilly's COVID-19 antibody therapies through a long-term manufacturing agreement, with the ultimate goal of making ...

2020-11-17 20:00 1609

Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atrial Shunt

Large randomized, sham-controlled trial evaluates interatrial shunting in a heart failure population currently without effective treatment TEWKSBURY, Mass., Nov. 17, 2020 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), today announce...

2020-11-17 19:00 998

Foresee Pharmaceuticals Enters Exclusive License Agreement with GenSci for the Commercialization of Camcevi(TM) in China

TAIPEI, Nov. 17, 2020 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO) ("Foresee") announced today that it has entered into an exclusive license agreement with GenScience Pharmaceuticals ("GenSci") - a wholly-owned subsidiary of Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ) - for ...

2020-11-17 17:51 2025

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect

2020-11-17 15:00 1635

Big Bets on Wuhan: United Imaging "at Full Steam" to Support Health Industry Upgrade

WUHAN, China, Nov. 16, 2020 /PRNewswire/ -- Wuhan, the epicenter of the COVID-19 outbreak, now stages an epic comeback as the second World Health Expo 2020 opens here onNov. 11, 2020. Industry thought leaders, including Margaret Chan Fung Fu-chun, former Director-General of WHO, Nobel laureates i...

2020-11-17 09:12 1562

Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases

MELBOURNE, Australia, Nov. 16, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the allowance of a new composition of matter patent by the United States Patent and Trademark Office (USPTO). The new patent is the product of in-ho...

2020-11-16 21:42 2845

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores

NANPING, China, Nov. 16, 2020 /PRNewswire/ -- Happiness Biotech Group Limited (the "Company" or Nasdaq: HAPP), an innovativeChina-based nutraceutical and dietary supplements producer, announced today that the Company's experience stores started offering Coenzyme Q10 - a best-selling product from ...

2020-11-16 21:00 3125

PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020

DAEJEON, South Korea, Nov. 16, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced today that the company will present the final results of the Phase IIa clinical trial of Olinvacimab for rGBM (recurrent glioblastoma multiforme) patients at SNO (Society of Neuro-Oncology) 2020. ...

2020-11-16 21:00 1444

PTC Therapeutics Announces Initiation of Phase 2/3 Clinical Trial in Australia to Evaluate PTC299 for the Treatment of COVID-19

– Oral treatment with novel dual-mechanism of action has the potential to address the two critical elements of COVID-19: viral replication and uncontrolled inflammatory response – – Randomized, double-blind, placebo-controlled, Phase 2/3 clinical study with two stages initiated at several sites ...

2020-11-16 05:00 1607

Biortus Announces Round A Financing and Launches Global Cryo-EM Innovation Center

WUXI, China, Nov. 13, 2020 /PRNewswire/ -- Wuxi Biortus Biosciences Co. Ltd. ("Biortus"), a global leader in structural biology service for drug discovery, recently closed round A financing withUS$15 million investment led by Bayland Capital, and the fund will be used to establish a global cryo-E...

2020-11-14 12:40 8842

China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

HAIKOU, China, Nov. 13, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2020-11-14 05:10 8448

China Biologic Products to Report Third Quarter 2020 Financial Results

BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its third quarter 2020 financial results o...

2020-11-13 21:00 7709

Almost half of working Australians say they need mental health support

Morneau Shepell's Mental Health Index™ for October continues to trend well below the pre-pandemic benchmark with a decline in work productivity MELBOURNE, Nov. 12, 2020 /PRNewswire/ -- Morneau Shepell, a leading provider of total wellbeing, mental health and digital mental health services, today ...

2020-11-12 22:34 1825

Green Shield Introduces New Face Masks for Beards

WESTMINSTER, Calif., Nov. 12, 2020 /PRNewswire/ -- Green Shield has introduced a new face mask for bearded consumers. While Green Shield's brand vision is that everyone has the right to protect themselves; and for millions of men who want to have a beard and also wear a protective face mask that ...

2020-11-12 19:19 1031

Casio to Exhibit Medical Camera for Global Market at virtual.MEDICA 2020

TOKYO, Nov. 12, 2020 /PRNewswire/ -- Casio Computer Co., Ltd. announced on October 22, 2020 that it will unveil its medical camera to the global market for the first time at virtual. MEDICA 2020, one of the world's largest medical device exhibitions, which will be held online this year fromNovemb...

2020-11-12 17:12 1893

Intelligent temperature detection device produced by ICETECH is favored by global market, helping pandemic prevention

BEIJING, Nov. 11, 2020 /PRNewswire/ -- As the epidemic continues, countries keep improving prevention measures and policies. As more peoplereturn to work and production is encouraged by the government,  a kind of smart device which could quickly and correctly perform temperature measurement and f...

2020-11-12 08:00 1186

Spine Innovations gains its independence, aims for massive growth in sales of its ESP® Disc Replacements in Spine

HEIMSBRUNN, France, Nov. 11, 2020 /PRNewswire/ -- Following the acquisition of its parent company FH Ortho by Olympus Corporation, Spine Innovations has become a fully independent company — and dedicated itself to worldwide sales deployment of its ESP® disc replacements. This development demonstr...

2020-11-12 03:45 1335

OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines

* The collaboration will develop an innovative genomic-based clinical treatment platform * The goal of the collaboration is to accelerate the R&D and commercialization of innovative medicines SHANGHAI, Nov. 11, 2020 /PRNewswire/ --OrigiMed, a China-based leading precision medicine company and...

2020-11-11 21:26 7347
1 ... 195196197198199200201 ... 219